JPRN-UMIN000049071尚未招募Unknown
Effects of imeglimin in patients with type 2 diabetes mellitus - Effects of imeglimin in patients with type 2 diabetes mellitus
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with a history of severe ketoacidosis, diabetic coma, or pre-coma Patients with malignant tumors and other serious diseases with poor prognosis Impaired renal function: eGFR <45 mL/min/1.73 m2
研究者
相似试验
招募中
不适用
Durable effect of imeglimin on the glycemic control in patients with type 2 diabetes mellitus: a multicenter, open-label, randomized, controlled trialType 2 diabetes mellitusJPRN-jRCTs031210623Bouuchi Ryoutarou567
尚未招募
不适用
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
招募中
不适用
Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitustype 2 Diabetes MellitusJPRN-UMIN000017461ephrology, endocrinology and vascular medicine at Tohoku University Hospital60
已完成
不适用
The efficacy of omarigliptin in type 2 diabetic patientsJPRN-UMIN000026700Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group41
尚未招募
4 期
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100